DAV's reply notwithstanding, it would seem nonsensical to me that a warning about possible development of glocuse intolerance would not be included in the generic version as the risk would be exactly the same as the branded drug. Is this what the labeling issue is for the generic?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.